This study investigated whether transplantation of Schwann cells differentiated from adipose-derived stem cells (ADSC-SCs) of rats could promote functional improvement after contusion brain injury, with a focus on the effect on reactive gliosis. ADSCs were isolated and expanded from groin adipose tissue of Sprague-Dawley rats and then differentiated into Schwann cells. ADSC-SCs were transplanted into the contused rat brain. Immunofluorescence and Western blotting were used to analyse reactive gliosis, and locomotor function of the rats was assessed. Hemiparalysed rats transplanted with ADSC-SCs showed significant locomotor function recovery compared with rats transplanted with undifferentiated ADSCs or control rats injected with medium alone. Transplanted ADSC-SCs significantly reduced glial scar formation and neurocan protein levels compared with transplanted undifferentiated ADSCs. In conclusion, transplantation of ADSC-SCs can effectively promote locomotor functional recovery and reduce reactive gliosis after contusion brain injury in rats.
Introduction
Schwann cells (SCs) play a pivotal role in repairing injury to the peripheral nervous system.
Numerous studies have demonstrated that transplantation of exogenous peripheral nerve SCs can improve motor function after spinal cord injury. 1 -3 The invasive nature of the surgical biopsy required for nerve harvest, together with difficulties in purification and culture of SCs from adult nerve tissue, 4 have hindered the clinical application of SCs. The ideal transplantable cell should be easily accessible and able to proliferate rapidly in culture, as well as being able to integrate successfully into host tissue and be tolerated immunologically. 5 The adipose-derived stem cell (ADSC) is a self-renewing and multipotent precursor with a high growth rate. 6 It represents a highly accessible and L Yang, JS Fang, W Wang et al.
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potentially autologous source of adult precursor cells, capable of generating functional SCs. 7 Central nervous system (CNS) injury leads to upregulation of reactive gliosis and the eventual formation of glial scar tissue. 8 Cells within the scar secrete many neurodevelopmental inhibitor molecules, hampering axon elongation and the establishment of new neuronal circuits. 9 The aim of the present study was, therefore, to investigate whether ADSC-SC transplantation could promote functional improvement after contusion brain injury in rats, with a focus on reactive gliosis.
Materials and methods ANIMALS
This study utilized 93 adult male Sprague-Dawley rats with a weight range of 230 -260 g. All procedures were approved by the Experimental Animal Centre, Xiangya School of Medicine of Central South University, Changsha, Hunan, China. Rats were maintained at a constant temperature (22 ± 2°C) with a 12-h light-dark cycle (lights on at 06.00 h), with food and water freely available.
PREPARATION OF ADSCs
The ADSCs were cultured as described previously. 6, 7 Adipose tissue from the rat groin region was cut into 1-mm 3 pieces and digested with 0.15% (w/v) collagenase type I for 60 min at 37°C with intermittent shaking. Enzyme activity was neutralized with low-glucose α-modified Eagle's medium (α-MEM; Gibco ® Cell Culture, Invitrogen, Carlsbad, CA, USA), containing 10% fetal bovine serum (FBS; Hyclone Laboratories, Logan, UT, USA). The tissue was mechanically dissociated by passing repeatedly through a 5-ml pipette and filtered through a 70-µm filter (Jianhu Inc., Daoxu, Zhejiang Province, China) to remove any undissociated tissue before being centrifuged at 800 g for 10 min to obtain a pellet. The pellet was resuspended in lowglucose α-MEM containing 10% FBS and again filtered through the 70-µm filter prior to incubation at 37°C with 5% carbon dioxide in control medium (low-glucose α-MEM, 10% FBS, 1% penicillin/streptomycin) for 24 h. Plates were washed thoroughly with 1 × Hank's balanced salt solution (HBSS; pH 7.2) to remove residual non-adherent red blood cells. The resulting cell population was maintained in control medium at 37°C with 5% carbon dioxide, until 80 -90% confluency was reached. Cells were passaged by incubation in oxygenized 1 × HBSS with 0.25% trypsin at 37°C for 5 min, mechanically dissociated to single cells and plated in culture flasks (Corning Gilbert, Glendale, AZ, USA) at a density of 10 -25 × 10 3 cells/ml. All cells underwent 3 -5 passages before any transplantation.
DIFFERENTIATION OF ADSCS TO SCHWANN CELLS
Isolated ADSCs were differentiated as described previously. 7, 10, 11 ADSCs (at passages 3 -5) were dissociated, plated onto 10-cm culture plates (Corning Gilbert) coated with poly-D-lysine/laminin, and cultured in mesenchymal stem cell (MSC) growth medium (low-glucose α-MEM, 10% FBS) containing 1 mM β-mercaptoethanol for 24 h. Cells were then washed with 1 × HBSS and the medium replaced with MSC growth medium containing 35 ng/ml alltrans-retinoic acid for 72 h. After 72 h, the cells were washed with 1 × HBSS and the medium replaced with MSC growth medium containing 5 ng/ml platelet-derived growth factor AA, 10 ng/ml basic fibroblast growth factor, 5.7 µg/ml forskolin and 252 ng/ml glial growth factor 2. Cultures were L Yang, JS Fang, W Wang et al.
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incubated for 14 days and the medium replaced every 3 days. Proliferating ADSC-SC colonies were isolated using cloning cylinders, trypsinized from the dish and replated in the same medium. Cultures of increasing purity were obtained by sequential passaging as confluency was reached.
TRANSFECTION OF GREEN FLUORESCENT PROTEIN
Cells were plated in six-well cell culture plates (Corning Gilbert), at 4 -5 × 10 4 cells in 2 ml low-glucose α-MEM containing 10% FBS (without antibiotics) 1 day before transfection, to ensure 90 -95% confluency at the time of transfection. The transfection reagent, pZsGREEN1-1 vector-Lipofectamine™ 2000 (pZsGREEN1-1 vector; Clontech, Mountain View, CA, USA; Lipofectamine™ 2000; Invitrogen) was prepared as follows: (i) 7.5 µl pZsGREEN1-1 vector was diluted in 250 µl Opti-MEM ® I reduced-serum medium (Invitrogen) and mixed gently; (ii) 5 µl Lipofectamine™ 2000 was diluted in 250 µl Opti-MEM ® I and incubated at room temperature for 5 min; (iii) diluted pZsGREEN1-1 vector and Lipofectamine™ 2000 were combined, mixed gently, and incubated at room temperature for 20 min; and (iv) target cells were incubated with 125 µl pZsGREEN1-1 vector-Lipofectamine™ 2000 for 72 h at 37°C with 5% carbon dioxide.
TISSUE PROCESSING AND IMMUNOFLUORESCENCE
Immunocytochemistry was performed on plastic chamber slides. Cells were washed for 5 min in 1 × HBSS, fixed with 4% (v/v) paraformaldehyde-0.1 M phosphatebuffered saline (PBS; pH 7.2) for 20 min, and washed again. Non-specific binding sites were blocked by incubation for 15 min at room temperature in 10% non-specific serum corresponding to the species in which secondary antibodies were generated. Cells were characterized by incubating with primary antibodies at 4°C overnight, washing three times with 1 × HBSS and then incubating with Cy3 fluorescent-conjugated secondary antibodies for 2 h at room temperature. Primary antibodies were diluted in 0.01 M PBS, pH 7.2, containing 0.1% Triton X-100 and 2% non-specific serum, and comprised polyclonal rabbit glial fibrillary acidic protein antibody (GFAP; 1 : 200 dilution; Abcam, Cambridge, MA, USA) and polyclonal mouse S100b antibody (1 : 200 dilution; Abcam). Secondary antibodies were preadsorbed Cy3-conjugated goat antirabbit immunoglobulin G (IgG) (Hand L-chain specific; 1 : 100 dilution; Abcam) and preadsorbed Cy3-conjugated goat antimouse IgG (H-and L-chain specific; 1 : 100 dilution; Abcam). Negative controls either omitted primary antibodies or replaced them with irrelevant IgG.
For brain tissue immunofluorescence, 10µm longitudinal frozen sections were cut in the horizontal plane and mounted on Superfrost ® Plus slides (Thermo Fisher Scientific, Houston, TX, USA). Sections were permeabilized with 0.1% Triton X-100, and non-specific binding sites were subsequently blocked with 10% non-specific serum. For immunodetection, tissue sections were delipidized before staining and incubated with polyclonal rabbit GFAP primary antibody and goat antirabbit IgG secondary antibody as described above.
FLOW CYTOMETRY
The percentage of S-100 receptor positive cells (a SC marker) was assessed by flow cytometry after differentiation and expansion of ADSCs. Cultures were trypsinized using 0.02% trypsin-versene at L Yang, JS Fang, W Wang et al.
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37°C for 5 min and resuspended in 1 × HBSS with 10% FBS. Cells were then centrifuged at 800 g for 5 min, resuspended in 4% paraformaldehyde in 0.1 M PBS for 15 min at room temperature and washed twice by centrifugation at 800 g for 5 min in wash buffer (1 × HBSS with 1% bovine serum albumin [BSA]). Prior to immunostaining, cells were incubated in 1 × HBSS containing 0.3% Triton X-100 and 1% normal goat serum, with fluorescein isothiocyanateconjugated polyclonal mouse S100b antibody (1 : 100 dilution) or polyclonal mouse GFAP antibody (1 : 100 dilution; Abcam) for 30 min at 4°C. Cells were washed twice, as before, and resuspended in wash buffer. Staining was visualized using goat antimouse IgG (1 : 100 dilution) with 1% BSA. Exposure to primary antibody was omitted for negative controls. Analysis was performed with a BD FACSCalibur™ flow cytometer (BD Biosciences, San Jose, CA, USA), using WinMDI 2.9 software (Scripps Research Institute, San Diego, CA, USA).
BRAIN CONTUSION INJURY AND CELL TRANSPLANTATION
A total of 52 adult male Sprague-Dawley rats (230 -260 g) were acclimatized to the behavioural testing environment and behavioural baselines were established. Surgery was performed under aseptic conditions, body temperature was maintained at > 36°C throughout the surgical and postoperative period, and blood oxygenation level and heart rate were monitored. Rats were anaesthetized with 120 mg/kg phenobarbital sodium via intraperitoneal injection, with 50 µg/kg atropine i.m. injection to reduce tracheal secretion. The head was mounted in a stereotactic apparatus, and the scalp was disinfected and shaved along the midline to expose the anterior fontanelle, sagittal suture and coronal suture. A small piece of periosteum from the left frontal bone (2 mm from the midline and 1 mm before the coronal suture) was removed and placed in 0.9% saline solution. The hole was extended to 4 × 6 mm, the dura was cut, and the cerebral cortex was contused from 4 mm before to 2 mm past the coronal suture, 4 mm from the midline at a depth of 3 mm. A 2 × 2 × 2 mm section of motor cortex (according to the stereotaxic atlas 12 ) was excised using fine surgical instruments. The wound was thoroughly staunched and covered by the periosteum before tightly suturing the scalp. All surgeries were performed under a microscope. A sham surgery consisting of scalp incision and osteosomy procedures was carried out in six rats, with the brain structure remaining intact. Rats received 5 ml Ringer's solution subcutaneous injection once a day for hydration and 0.3 mg/kg buprenorphine i.m. injection once a day to alleviate pain immediately following surgery and for the first postoperative day.
Contusion injured animals were randomly divided into three groups 7 days after surgery: undifferentiated ADSC transplantation; ADSC-SC transplantation; and control (10 µl α-MEM injection). Immediately prior to transplantation, the appropriate cell cultures were digested with 1 mg/ml collagenase and gently triturated to yield a single cell suspension. Cells were resuspended with α-MEM at a final concentration of 2 × 10 5 cells/µl and a total volume of 10 µl was stereotaxically injected into the cavity of the injured cortex using a 10-µl Hamilton syringe fitted with a glass micropipette. All animals received 15 mg/kg cyclosporine A subcutaneous injection daily, beginning 2 days before transplantation and continuing for the duration of the experiment.
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A subset of animals was sacrificed on day 7 after transplantation for immunofluorescence or Western blot analysis to assess quantitatively the effect of ADSC-SCs transplantation on reactive gliosis.
BEHAVIOURAL ASSESSMENT
Behavioural testing was performed during the light cycle (06.00 -18.00 h) 1 -2 days before injury, to establish baseline values. Locomotor function was assessed using the neurological scoring system described by Faden et al. 13 in order to compare the functional outcome of various treatments over time. Tests were performed on day 6 after surgery and animals with scores < 9 and > 11 were eliminated in order to standardize the severity of injury. Transplantation took place on day 7 and behavioural testing was performed on days 10, 14, 21 and 30 after injury.
Motor function tests, performed three times during each assessment and measured according to the neurological scoring system of Faden et al., 13 were recorded by two observers who were blinded to treatment groups. Each test was scored via an ordinal scale ranging from zero (severely impaired) to five (normal function). The ability to maintain position on an inclined plane in a vertical and two horizontal positions for 5 s, right and left forelimb flexion and right and left lateral pulsion were assessed. The seven individual scores were added to yield an overall score ranging from 0 to 35. with Blotto A (ProMab Biotechnologies, Richmond, CA, USA), which comprised 1 × Tris-buffered saline, 0.05% Tween-20 (TBST; pH 6.8) and 5% milk (nonfat dried milk powder), for 4 h at 4°C. Membranes were probed overnight with rabbit antirat neurocan antibody (1 : 200 dilution; Bioss, Beijing, China) for 2 h at room temperature, washed three times in 1 × TBST for 10 min, incubated with horseradish peroxidase-conjugated goat antirabbit IgG (1 : 40 000 dilution; Bioss) for 1 h at room temperature, and washed three times with 1 × TBST. Blots were developed with enhanced chemi luminescence (ECL) using a Pierce Protein Research Products ECL kit (Thermo Fisher Scientific) and exposed to X-ray film. Images were recorded with a Kodak Digital Imaging System (Eastman Kodak, Rochester, NY, USA), digitized and densitometrically analysed with Gel-Pro Analyzer software, version 4 (Media Cybernetics, Bethesda, MD, USA). Membranes were also probed with antibodies to glyceraldehyde 3-phosphate dehydrogenase as an internal control using the procedure described above.
WESTERN BLOTTING

STATISTICAL ANALYSES
Statistical analyses were performed with SPSS ® statistical package, version 10.0 (SPSS Inc., Chicago, IL, USA) for Windows ® . Data L Yang, JS Fang, W Wang et al.
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are presented as mean ± SE. One-way analysis of variance with post-hoc pairwise comparison was used for comparison of multigroup means. Data that violated the assumptions of normality and/or homogeneity of variance were analysed with Dunnett's C test. A P-value < 0.05 was considered to be statistically significant.
Results
ADSC CULTURE
Several ADSCs with a short spindle or polygonal shape were found adhering to culture plates 24 h after initial plating of the primary culture ( Fig. 1A) . Cell numbers were vastly increased at 72 h and fibroblast-like colonies were present. After 1 week, ADSCs formed a uniformly aligned monolayer of fibroblast-like cells (Fig. 1B) . As cultures approached confluence, cells showed a more fibroblast-like morphology. ADSCs grew robustly within five passages, but proliferation decreased after 10 passages and cells appeared irregular and fatter than before (Fig. 1C) . After transfection, > 95% of the cells expressed green fluorescent protein ( Fig. 2A, 2B ).
ADSC TO SC DIFFERENTIATION
After the induction of differentiation, the size and shape of the cultured ADSCs were similar to those of genuine SCs, with a spindle-shaped body and some slender apophysis (Fig. 3A) . To characterize differentiated ADSCs, cells were evaluated for the presence of the SC-specific markers GFAP and S-100. 14, 15 Faint GFAP staining and no S-100 staining were observed in undifferentiated ADSCs. In contrast, 
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differentiated ADSC-SCs showed increased GFAP staining ( Fig. 3B) and some S-100 staining (Fig. 3C ). Flow cytometry demonstrated that > 85% of differentiated ADSCs were positive for S-100 ( Fig. 3D ). After transfection, > 95% of ADSC-SCs expressed green fluorescent protein (Fig. 2C, 2D ).
ESTABLISHMENT OF RAT BRAIN INJURY MODEL
There was no locomotor function deficit in any rat prior to surgery. After surgical brain injury, all animals displayed gross motor impairment but none was completely paralysed; the neurological function score was between 9 and 11 indicating severe contralateral neurological deficits. Rats in the sham surgery group exhibited no functional deficits. Extensive surgical damage to the rat motor cortex resulted in a stable model of contralateral hemiplegia.
FUNCTIONAL IMPROVEMENT AFTER CONTUSION INJURY
Behavioural assessment via the neurological scoring system of Faden et al., 13 was used to verify the functional locomotor recovery of injured rats. There were no significant 
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between-group differences in locomotor function on day 6 postinjury. All animals in the control group (n = 8) showed varying levels of slight recovery after injury. In contrast, significant locomotor recovery was observed in animals transplanted with ADSCs (n = 18) or ADSC-SCs (n = 20) on day 10 after injury, compared with controls. The improvement in functional locomotor recovery of rats transplanted with ADSC-SCs was larger and more sustained (peaking at day ≥ 30) than in rats transplanted with ADSCs, which had a lower level of recovery, peaking at day 21 (Fig. 4 ).
MODIFICATION OF REACTIVE GLIOSIS BY TRANSPLANTED ADSC-SCs
Glial scar formation around the injury was visible on day 7 post-transplantation. Fluorescence microscopy revealed minimal astrocytic response to ADSC-SCs, with extensive intermingling between transplanted cells and the host reactive gliosis, and no obvious barrier between the transplant and host tissue (Fig. 5A ). This was in contrast to the ADSC and control groups which showed the presence of a thick glial scar with high levels of GFAP (Fig. 5B, 5C ), 
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and a sharp border between the transplant and host tissue in the ADSC group indicating that transplanted cells were not infiltrating into the host tissue ( Fig. 5B ). Transplantation of ADSC-SCs significantly reduced the expression of neurocan (P < 0.05) compared with the ADSC and control groups (Fig. 6 ). There was a negative correlation between the neurological function score and relative neurocan protein levels (r = -0.437, P = 0.021).
Discussion
Adipose-derived stem cells and neural stem cells are known to promote functional improvement after CNS injury. 16 -20 When the axon is injured, its distal end degenerates, proliferated SCs engulf the axon and disintegrated myelin, and arrange themselves along the inside of the neural tube, forming a solid cell cord (Bungner cord) to connect the two ends. 21 SCs also synthesize and secrete various neurotrophic factors. 22 -25 The non-permissive environment of the CNS prevents the spontaneous regeneration of injured axons. 26 David and Lacroix 27 found that transplanting exogenous SCs with a matrigel vessel into the injured spinal cord could promote the regeneration of axons capable of responding to electrical stimulation. Myelinating SCs have been differentiated from rat bone marrow MSCs 28 and skin-derived precursors. 29 Skin-derived precursor SCs (SKP-SCs) survived 12 weeks after transplantation into injured spinal cord, reduced the size of the contusion cavity, myelinated endogeneous host axons, reduced reactive gliosis and provided an environment that was highly conducive to axonal growth. 29 SKP-SCs enhanced locomotor recovery compared with both SKPs and forebrain subventricular zone 29 In the present study, ADSC-SCs transplanted into the contusion injured cerebral cortex led to greater locomotor function recovery than controls and animals transplanted with undifferentiated ADSCs.
Glial scar formation occurs after CNS injury and is a reactive cellular process involving astrogliosis. 30 Reactive astrocytes are the main cellular component of the glial scar, increasing in both number and size after injury, with increased and extended processes and unregulated expression of GFAP. 31, 32 Glial scar formation has been shown to have both positive and negative effects on neurodegeneration, 33, 34 however, excessive glial scarring is believed to be detrimental. Excessive scarring forms a direct physical barrier and cells within the scar secrete many neurodevelopmental inhibitor molecules that prevent complete physical and functional recovery of the CNS after injury or disease. 9, 30, 35 Astrocytes secrete several molecules that inhibit the growth of axonal extensions, including chondroitin sulphate proteoglycans (CSPGs), keratan sulphate proteoglycans and the close homologue of adhesion molecule L1. 36 -39 Injection of NG2 antibody (NG2 is a CSPG) has been shown to facilitate axonal extension of injured sensory nerves through the glial scar. 40 Chondroitinase ABC 41,42 and hyaluronidase 43 (which binds to CSPGs) have also been shown to promote axon regeneration. Bone marrow stromal cells have been found to decrease scar wall thickness and improve brain function after stroke in rats. 44, 45 One of the consequences of the reactive 
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astrocyte response to brain injury is an increase in the levels of CSPGs, such as neurocan. 46 ADSC-SC transplantation in the present study caused minimal reactive gliosis, leading to the hypothesis that levels of inhibitory extracellular matrix molecules, such as neurocan, might be reduced. In order to address this hypothesis, the current study included quantitative analysis of neurocan protein levels.
Neurocan is one of the major CSPGs in nervous tissue and its expression and proteolytic cleavage are developmentally regulated in the normal rat brain. 47 GFAP-positive astrocytes are a major source of neurocan 48 and neurocan levels are significantly upregulated after CNS injury. 46 The transplantation of retinal progenitor cells has been shown to induce matrix metalloproteinase-2 secretion, resulting in neurocan proteolysis and significantly increasing neurite outgrowth across the border between abutting non-dystrophic and rd1 retinas in vitro. 49 The enhanced level of migration and integration of grafted retinal progenitor cells has been partially associated with decreased neurocan expression. 50 Treatment with anti-XT-1 mRNA FIGURE 6: Western blotting for brain neurocan protein levels in rats with contusion brain injury transplanted with rat adipose-derived stem cells (ADSCs), ADSCs differentiated to Schwann cells (ADSC-SCs) or control injection (αmodified Eagle's medium decreased neurocan expression and promoted axon growth through the scar tissue in injured spinal cord, 51 and transplanted bone marrow stromal cells promote axonal regeneration by reducing neurocan expression in the ischaemic rat brain. 48 These experimental findings highlight a role for neurocan during tissue repair and neural network reconstitution after CNS injury.
The present study demonstrated that transplantation with ADSC-SCs inhibits reactive gliosis and reduces neurocan protein levels. The negative correlation between neurological function score and relative protein level of neurocan suggests that transplanted ADSC-SCs may promote locomotor function recovery by reducing neurocan levels. The finding that transplanted ADSC-SCs integrated with the surrounding host tissue is also of interest and suggests that ADSC-SCs could make contact with host cells, which could be an important basis for transferring information to each other. In contrast, undifferentiated ADSCs showed poor contact with host cells, with a thick glial scar separating the graft from the host tissue.
The ADSC-SCs have several advantages over other cell types. ADSCs can be easily obtained via liposuction and represent an accessible, potentially autologous, source of tissue. In contrast, embryonic stem cells and CNS neural stem cells are derived from heterologous cell sources, and nerve-derived SCs must be harvested by invasive nerve biopsy. ADSCs are an adult human precursor population of cells and, therefore, circumvent potential ethical issues surrounding the use of fetal tissue. Several studies have shown that human ADSCs can be expanded robustly, 52 -54 behaving similarly to immature developing SCs. This is in contrast to nerve-derived SCs, which are mature and have limited proliferation potential. 55 ADSCs can be derived from a wide range of sources and can be readily obtained and cultured in vitro.
In conclusion, the present study has demonstrated that transplanted ADSC-SCs can modify glial scar formation and improve locomotor function after brain injury in rats. ADSC-SC transplantation, therefore, appears to offer a viable potential strategy for the repair of brain injury, promoting greater locomotor function recovery and reducing reactive gliosis compared with undifferentiated ADSCs.
